Wei “Vivian” Wang, Ph.D., in the department of pharmaceutical outcomes and policy and Haesuk Park, Ph.D., an associate professor in the department, led the study.
The University of Florida College of Pharmacy celebrates women advancing the pharmaceutical sciences during the fifth International Day of Women and Girls in Science on Feb. 11. Five female faculty members and five graduate students were asked to share a message with aspiring young, female pharmaceutical scientists.
Park's tenure and promotion to associate professor became official on July 1.
UF College of Pharmacy researchers will investigate whether telehealth will improve asthma medication adherence and health outcomes.
The study, published in the journal Hepatology, examined the clinical and economic outcomes of direct-acting antiviral therapy, which cures hepatitis C in nearly 95 percent of patients.
UF College of Pharmacy researchers led the study featuring approximately 15,000 patients.
Her research proposal that won her the award investigates the impact of Medicaid prior authorization policies on prescribers’ HCV-infected patients' outcomes.
The article titled, "Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD," was selected for an editorial highlight by the journal which has an impact factor of 13.25.
Proteus Digital Health has awarded funding to Haesuk Park, Ph.D., to study the effectiveness of recently FDA-approved digital medicine, Abilify MyCite.
Study included collaboration with UF Medication Therapy Management Communication and Care Center.
